{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:15:42Z","timestamp":1769858142334,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41409-018-0162-0","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T13:52:06Z","timestamp":1523627526000},"page":"1319-1327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis"],"prefix":"10.1038","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-9618","authenticated-orcid":false,"given":"Lucas C. M.","family":"Arruda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joa\u0303o R.","family":"Lima-Ju\u0301nior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-5039","authenticated-orcid":false,"given":"Emmanuel","family":"Clave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela A.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Douay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He\u0301le\u0300ne","family":"Moins-Teisserenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimas T.","family":"Covas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda P.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7308-7317","authenticated-orcid":false,"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-0086","authenticated-orcid":false,"given":"Kelen C. R.","family":"Malmegrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-2222","authenticated-orcid":false,"given":"Maria Carolina","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"162_CR1","first-page":"30933","volume":"S0140-6736","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;S0140-6736:30933\u20139.","journal-title":"Lancet"},{"key":"162_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3324\/haematol.2009.013458","volume":"95","author":"D Farge","year":"2010","unstructured":"Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Laar Van J, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica. 2010;95:284\u201392.","journal-title":"Haematologica"},{"key":"162_CR3","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM Laar van","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis. JAMA. 2014;311:2490\u20138.","journal-title":"JAMA"},{"key":"162_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/bmt.2016.211","volume":"52","author":"N Papa Del","year":"2016","unstructured":"Del Papa N, Onida F, Zaccara E, Saporiti G, Maglione W, Tagliaferri E, et al. Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis. Bone Marrow Transplant. 2016;52:53\u201358.","journal-title":"Bone Marrow Transplant"},{"key":"162_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20041679","volume":"201","author":"Pa Muraro","year":"2005","unstructured":"Muraro Pa, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 2005;201:805\u201316.","journal-title":"J Exp Med"},{"key":"162_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","volume":"127","author":"EM Delemarre","year":"2016","unstructured":"Delemarre EM, Van Den Broek T, Mijnheer G, Meerding J, Wehrens EJ, Olek S, et al. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells. Blood. 2016;127:91\u2013101.","journal-title":"Blood"},{"key":"162_CR7","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1093\/brain\/awt182","volume":"136","author":"SV Abrahamsson","year":"2013","unstructured":"Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, et al. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain. 2013;136:2888\u2013903.","journal-title":"Brain"},{"key":"162_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/art.21036","volume":"52","author":"D Farge","year":"2005","unstructured":"Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C, et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum. 2005;52:1555\u201363.","journal-title":"Arthritis Rheum"},{"key":"162_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","volume":"10","author":"D Farge","year":"2017","unstructured":"Farge D, Arruda LCM, Brigant F, Clave E, Douay C, Marjanovic Z, et al. Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients. J Hematol Oncol. 2017;10:21.","journal-title":"J Hematol Oncol"},{"key":"162_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","volume":"113","author":"T Alexander","year":"2009","unstructured":"Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S, et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood. 2009;113:214\u201323.","journal-title":"Blood"},{"key":"162_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072","volume":"2","author":"Lucas C. M. Arruda","year":"2018","unstructured":"Lucas C. M. Arruda, Kelen C. R. Malmegrim, Jo\u00e3o R. Lima-J\u00fanior, Emmanuel Clave, Juliana B. E. Dias, Daniela A. Moraes, Corinne Douay, Isabelle Fournier, H\u00e9l\u00e8ne Moins-Teisserenc, Ant\u00f4nio Jos\u00e9 Alberdi, Dimas T. Covas, Belinda P. Sim\u00f5es, Pauline Lansiaux, Antoine Toubert, Maria Carolina Oliveira, (2018) Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances 2 (2):126\u2013141","journal-title":"Blood Advances"},{"key":"162_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/bmt.2014.277","volume":"50","author":"LCM Arruda","year":"2015","unstructured":"Arruda LCM, Lorenzi JCC, Sousa APA, Zanette DL, Palma PVB, Panepucci RA, et al. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplant. 2015;50:380\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"162_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","volume":"169","author":"LCM Arruda","year":"2016","unstructured":"Arruda LCM, de Azevedo JTC, de Oliveira GLV, Scortegagna GT, Rodrigues ES, Palma PVB, et al. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation. Clin Immunol. 2016;169:47\u201357.","journal-title":"Clin Immunol"},{"key":"162_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm965","volume":"10","author":"Z Wu","year":"2004","unstructured":"Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med. 2004;10:87\u201392.","journal-title":"Nat Med"},{"key":"162_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1172\/JCI71691","volume":"124","author":"PA Muraro","year":"2014","unstructured":"Muraro PA, Robins H, Malhotra S, Howell M, Phippard D, Desmarais C, et al. T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J Clin Invest. 2014;124:1168\u201372.","journal-title":"J Clin Invest"},{"key":"162_CR16","doi-asserted-by":"publisher","first-page":"e19687","DOI":"10.1371\/journal.pone.0019687","volume":"6","author":"A O\u2019Donovan","year":"2011","unstructured":"O\u2019Donovan A, Pantell MS, Puterman E, Dhabhar FS, Blackburn EH, Yaffe K, et al. Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS ONE. 2011;6:e19687.","journal-title":"PLoS ONE"},{"key":"162_CR17","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMra0903373","volume":"361","author":"RT Calado","year":"2009","unstructured":"Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009;361:2353\u201365.","journal-title":"N Engl J Med"},{"key":"162_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.bmt.1702144","volume":"25","author":"M Akiyama","year":"2000","unstructured":"Akiyama M, Asai O, Kuraishi Y, Urashima M, Hoshi Y, Sakamaki H, et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2000;25:441\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"162_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1182\/blood.V97.2.575","volume":"97","author":"N Rufer","year":"2001","unstructured":"Rufer N, Br\u00fcmmendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood. 2001;97:575\u20137.","journal-title":"Blood"},{"key":"162_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/sj.bmt.1703069","volume":"27","author":"J Robertson","year":"2001","unstructured":"Robertson J, Testa N, Russell N, Jackson G, Parker A, Milligan D, et al. Telomere length Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant. Bone Marrow Transplant. 2001;27:1283\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"162_CR21","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1182\/blood-2012-01-403337","volume":"120","author":"R Peffault de Latour","year":"2012","unstructured":"Peffault de Latour R, Calado RT, Busson M, Abrams J, Adoui N, Robin M, et al. Age-adjusted recipient pre-transplant telomere length and treatment-related mortality after hematopoietic stem cell transplantation. Blood. 2012;120:3353\u20139.","journal-title":"Blood"},{"key":"162_CR22","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen Van Den","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"162_CR23","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"162_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","volume":"381","author":"RK Burt","year":"2013","unstructured":"Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M, et al. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Lancet. 2013;381:1116\u201324.","journal-title":"Lancet"},{"key":"162_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","volume":"8","author":"KCR Malmegrim","year":"2017","unstructured":"Malmegrim KCR, de Azevedo JTC, Arruda LCM, Abreu JRF, Couri CEB, de Oliveira GLV, et al. Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes. Front Immunol. 2017;8:167.","journal-title":"Front Immunol"},{"key":"162_CR26","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","volume":"37","author":"RM Cawthon","year":"2009","unstructured":"Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009;37:e21.","journal-title":"Nucleic Acids Res"},{"key":"162_CR27","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009;37:e45\u2013e45.","journal-title":"Nucleic Acids Res"},{"key":"162_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.humimm.2010.01.024","volume":"71","author":"G Frisullo","year":"2010","unstructured":"Frisullo G, Nociti V, Iorio R, Plantone D, Patanella AK, Tonali PA, et al. CD8+Foxp3+T cells in peripheral blood of relapsing-remitting multiple sclerosis patients. Hum Immunol. 2010;71:437\u201341.","journal-title":"Hum Immunol"},{"key":"162_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4049\/jimmunol.1200886","volume":"189","author":"AJ Beres","year":"2012","unstructured":"Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR. CD8+Foxp3+regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J Immunol. 2012;189:464\u201374.","journal-title":"J Immunol"},{"key":"162_CR30","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/brain\/awh117","volume":"127","author":"W Sun","year":"2004","unstructured":"Sun W, Popat U, Hutton G, Zang YCQ, Krance R, Carrum G, et al. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain. 2004;127:996\u20131008.","journal-title":"Brain"},{"key":"162_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ana.23784","volume":"73","author":"PJ Darlington","year":"2013","unstructured":"Darlington PJ, Touil T, Doucet JS, Gaucher D, Zeidan J, Gauchat D, et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol. 2013;73:341\u201354.","journal-title":"Ann Neurol"},{"key":"162_CR32","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","volume":"107","author":"I Kleer De","year":"2006","unstructured":"De Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+immune regulatory network. Blood. 2006;107:1696\u2013702.","journal-title":"Blood"},{"key":"162_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.it.2005.12.003","volume":"27","author":"PA Muraro","year":"2006","unstructured":"Muraro PA, Douek DC. Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol. 2006;27:61\u201367.","journal-title":"Trends Immunol"},{"key":"162_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.retram.2016.03.004","volume":"64","author":"LCM Arruda","year":"2016","unstructured":"Arruda LCM, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases. Curr Res Transl Med. 2016;64:107\u201313.","journal-title":"Curr Res Transl Med"},{"key":"162_CR35","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1136\/ard.2007.086652","volume":"67","author":"A MacIntyre","year":"2008","unstructured":"MacIntyre A, Brouilette SW, Lamb K, Radhakrishnan K, McGlynn L, Chee MM, et al. Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion. Ann Rheum Dis. 2008;67:1780\u20132.","journal-title":"Ann Rheum Dis"},{"key":"162_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00296-007-0472-9","volume":"28","author":"F Tarhan","year":"2008","unstructured":"Tarhan F, Vural F, Kosova B, Aksu K, Cogulu O, Keser G, et al. Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis. Rheumatol Int. 2008;28:579\u201383.","journal-title":"Rheumatol Int"},{"key":"162_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1182\/blood-2002-06-1832","volume":"101","author":"H Roelofs","year":"2003","unstructured":"Roelofs H, De Pauw ESD, Zwinderman AH, Opdam SM, Willemze R, Tanke HJ, et al. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood. 2003;101:358\u201362.","journal-title":"Blood"},{"key":"162_CR38","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.4049\/jimmunol.156.10.3587","volume":"156","author":"J Monteiro","year":"1996","unstructured":"Monteiro J, Batliwalla F, Ostrer H, Gregersen PK. Shortened telomeres in clonally expanded CD28\u2212CD8+T cells imply a replicative history that is distinct from their CD28+CD8+counterparts. J Immunol. 1996;156:3587\u201390.","journal-title":"J Immunol"},{"key":"162_CR39","doi-asserted-by":"publisher","first-page":"F17","DOI":"10.1097\/00002030-199607000-00001","volume":"10","author":"RB Effros","year":"1996","unstructured":"Effros RB, Allsopp R, Chiu CP, Hausner MA, Hirji K, Wang L, et al. Shortened telomeres in the expanded CD28\u2212CD8+cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 1996;10:F17\u201322.","journal-title":"AIDS"},{"key":"162_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fimmu.2017.00031","volume":"8","author":"Y Vuddamalay","year":"2017","unstructured":"Vuddamalay Y, van Meerwijk JPM. CD28\u2212 and CD28lowCD8+regulatory T cells: of mice and men. Front Immunol. 2017;8:31.","journal-title":"Front Immunol"},{"key":"162_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/intimm\/10.3.311","volume":"10","author":"L Mollet","year":"1998","unstructured":"Mollet L, Sadat-Sowti B, Duntze J, Leblond V, Bergeron F, Calvez V, et al. CD8hi+CD57+T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol. 1998;10:311\u201323.","journal-title":"Int Immunol"},{"key":"162_CR42","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V77.10.2237.2237","volume":"77","author":"B Autran","year":"1991","unstructured":"Autran B, Leblond V, Sadat-Sowti B, Lefranc E, Got P, Sutton L, et al. A soluble factor released by CD8+CD57+lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood. 1991;77:2237\u201341.","journal-title":"Blood"},{"key":"162_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cellimm.2010.02.002","volume":"262","author":"Z Mikulkova","year":"2010","unstructured":"Mikulkova Z, Praksova P, Stourac P, Bednarik J, Strajtova L, Pacasova R, et al. Numerical defects in CD8+CD28\u2212 T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol. 2010;262:75\u20139.","journal-title":"Cell Immunol"},{"key":"162_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523:612\u20136.","journal-title":"Nature"},{"key":"162_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492\u20139.","journal-title":"Nat Immunol"},{"key":"162_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jaut.2011.02.009","volume":"36","author":"G Thangavelu","year":"2011","unstructured":"Thangavelu G, Parkman JC, Ewen CL, Uwiera RRE, Baldwin TA, Anderson CC. Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis. J Autoimmun. 2011;36:301\u201312.","journal-title":"J Autoimmun"},{"key":"162_CR47","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/blood-2008-12-192120","volume":"114","author":"A Campion Le","year":"2009","unstructured":"Le Campion A, Gagnerault MC, Auffray C, B\u00e9court C, Poitrasson-Rivi\u00e8re M, Lallemand E, et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood. 2009;114:1784\u201393.","journal-title":"Blood"},{"key":"162_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2249.2012.04583.x","volume":"168","author":"GLV Oliveira de","year":"2012","unstructured":"de Oliveira GLV, Malmegrim KCR, Ferreira AF, Tognon R, Kashima S, Couri CEB, et al. Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation. Clin Exp Immunol. 2012;168:291\u2013302.","journal-title":"Clin Exp Immunol"},{"key":"162_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/cei.12895","volume":"187","author":"GLV Oliveira de","year":"2017","unstructured":"de Oliveira GLV, Ferreira AF, Gasparotto EPL, Kashima S, Covas DT, Guerreiro CT, et al. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation. Clin Exp Immunol. 2017;187:383\u201398.","journal-title":"Clin Exp Immunol"},{"key":"162_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cyto.a.22351","volume":"85","author":"A Larbi","year":"2014","unstructured":"Larbi A, Fulop T. From \u2018truly na\u00efve\u2019 to \u2018exhausted senescent\u2019 T cells: when markers predict functionality. Cytom Part A. 2014;85:25\u201335.","journal-title":"Cytom Part A"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0162-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:17:47Z","timestamp":1693624667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0162-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0162-0","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"22 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}